229 related articles for article (PubMed ID: 1374977)
21. Measurements of serum gamma-seminoprotein and prostate specific antigen evaluated for monitoring carcinoma of the prostate.
Siddall JK; Shetty SD; Cooper EH
Clin Chem; 1986 Nov; 32(11):2040-3. PubMed ID: 2430732
[TBL] [Abstract][Full Text] [Related]
22. Gamma-seminoprotein--a new tumour marker in prostatic cancer? Results of a pilot study.
Maier U; Simak R
Br J Urol; 1990 May; 65(5):509-12. PubMed ID: 1693867
[TBL] [Abstract][Full Text] [Related]
23. [Comparison of 3 assay kits of prostate specific antigen in serum of prostatic cancer].
Akimoto S; Akakura K; Shimazaki J
Hinyokika Kiyo; 1988 Dec; 34(12):2143-8. PubMed ID: 2467543
[TBL] [Abstract][Full Text] [Related]
24. [Clinical evaluation of a prostate-specific antigen as a serum marker of prostatic cancer].
Park YC; Kiwamoto H; Nishioka T; Tsujihashi H; Mitsubayashi S; Matsuura T; Akiyama T; Kurita T; Miyamoto T
Hinyokika Kiyo; 1987 Jun; 33(6):883-8. PubMed ID: 2445188
[TBL] [Abstract][Full Text] [Related]
25. [Clinical evaluation of serum gamma-seminoprotein in patients with prostatic cancer].
Ishihara Y; Hiromoto Y; Higaki Y; Imamura K
Hinyokika Kiyo; 1989 Mar; 35(3):409-13. PubMed ID: 2660507
[TBL] [Abstract][Full Text] [Related]
26. [Clinical studies of gamma-seminoprotein in prostatic disease. I. Clinical evaluation of serum gamma-seminoprotein].
Hasegawa S; Nakashima J; Nakashima Y; Nakamura S; Kimura S
Hinyokika Kiyo; 1987 Dec; 33(12):2055-8. PubMed ID: 3329453
[TBL] [Abstract][Full Text] [Related]
27. [Relationship between reactivation and tumor markers in prostatic cancer].
Fuse H; Umeda K; Kazama T; Sakamoto M; Sakai T; Fujishiro Y; Mizuno I; Katayama T
Hinyokika Kiyo; 1991 Jan; 37(1):39-43. PubMed ID: 1707217
[TBL] [Abstract][Full Text] [Related]
28. [Significance of prostatic acid phosphatase, gamma-seminoprotein and prostatic specific antigen in the urine. First report: the measurement of PAP, gamma-Sm and PA in the urine of patients with prostatic diseases].
Uchijima Y; Yoshida K; Saitoh H
Hinyokika Kiyo; 1991 Oct; 37(10):1255-60. PubMed ID: 1721770
[TBL] [Abstract][Full Text] [Related]
29. [Studies on prostate specific antigen, gamma-seminoprotein (gamma-Sm) as a tumor marker of prostatic cancer].
Kamachi S; Sakurabayashi I; Kawai T
Rinsho Byori; 1984 Jul; 32(7):781-5. PubMed ID: 6389940
[No Abstract] [Full Text] [Related]
30. [The significance of serum gamma-seminoprotein in prostatic cancer].
Ishikawa S; Tozuka K; Ishiyama S; Goto K; Ohba S; Tokue A; Yonese Y; Kamachi S; Sakurabayashi I; Kawai T
Hinyokika Kiyo; 1985 Jun; 31(6):961-7. PubMed ID: 2414979
[TBL] [Abstract][Full Text] [Related]
31. [Usefulness of prostate specific antigen/gamma-seminoprotein ratio for diagnosis of prostate cancer].
Demura T; Watarai Y; Togashi M; Oohashi N; Chikaraishi T; Hirano T
Nihon Hinyokika Gakkai Zasshi; 1993 Jun; 84(6):1046-53. PubMed ID: 7688442
[TBL] [Abstract][Full Text] [Related]
32. [Clinical evaluation of gamma-seminoprotein as a serum marker of prostate carcinoma].
Sugimura Y; Sakurai M; Hioki T; Hayashi N; Yamakawa K; Tajima K; Tochigi H; Kawamura J
Hinyokika Kiyo; 1988 Dec; 34(12):2129-34. PubMed ID: 2467541
[TBL] [Abstract][Full Text] [Related]
33. Measurement of prostate specific antigen and gamma-seminoprotein ratio: a new means of distinguishing benign prostatic hyperplasia and prostate cancer.
Demura T; Watarai Y; Togashi M; Hirano T; Ohashi N; Koyanagi T
J Urol; 1993 Nov; 150(5 Pt 2):1740-5. PubMed ID: 7692111
[TBL] [Abstract][Full Text] [Related]
34. Diurnal rhythm of serum gamma-seminoprotein in patients with untreated prostate cancer: comparison of the original and revised assay kits.
Akimoto S; Akakura K; Ohki T; Shimazaki J
Int J Urol; 1994 Sep; 1(3):263-7. PubMed ID: 7542157
[TBL] [Abstract][Full Text] [Related]
35. [Measurements of prostatic acid phosphatase and prostate specific antigen by fully automated enzyme immunoassay system--its analytical and clinical evaluation].
Matui A; Yamada T; Sugita O; Yakata M
Rinsho Byori; 1990 Jun; 38(6):693-8. PubMed ID: 1696328
[TBL] [Abstract][Full Text] [Related]
36. [Prostate specific antigen (PSA)/gamma-seminoprotein ratio in the cases with PSA levels less than or equal to 10.0 ng/ml].
Demura T; Ohyama I; Togashi M; Ohashi N; Chikaraishi T; Hirano T; Koyanagi T
Nihon Hinyokika Gakkai Zasshi; 1995 Feb; 86(2):296-303. PubMed ID: 7534845
[TBL] [Abstract][Full Text] [Related]
37. Three predominant prostatic proteins.
Abrahamsson PA; Lilja H
Andrologia; 1990; 22 Suppl 1():122-31. PubMed ID: 1720287
[TBL] [Abstract][Full Text] [Related]
38. [gamma-Seminoprotein in serum of prostatic cancer].
Fuse H; Masukagami T; Kataumi Z; Shimazaki J
Hinyokika Kiyo; 1985 Jan; 31(1):81-5. PubMed ID: 3993497
[TBL] [Abstract][Full Text] [Related]
39. Histochemical study of R1881-binding protein, prostatic acid phosphatase, prostate-specific antigen, and r-seminoprotein in prostatic cancer.
Ito H; Yamaguchi K; Sumiya H; Matsuzaki O; Shimazaki J
Eur Urol; 1986; 12(1):49-53. PubMed ID: 2419136
[TBL] [Abstract][Full Text] [Related]
40. Two prostate-specific antigens, gamma-seminoprotein and beta-microseminoprotein.
Hara M; Kimura H
J Lab Clin Med; 1989 May; 113(5):541-8. PubMed ID: 2654306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
